2013
DOI: 10.1124/pr.111.005223
|View full text |Cite
|
Sign up to set email alerts
|

International Union of Basic and Clinical Pharmacology. LXXXVII. Complement Peptide C5a, C4a, and C3a Receptors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

7
248
0
1

Year Published

2014
2014
2021
2021

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 224 publications
(256 citation statements)
references
References 546 publications
(534 reference statements)
7
248
0
1
Order By: Relevance
“…In the acute setting, C3a prevents mobilization of neutrophils, limits their accumulation into tissues, and, therefore, reduces the inflammatory response at the tissue level. However, in certain chronic disease models, such as asthma and rheumatoid arthritis, C3a clearly demonstrates certain proinflammatory actions and contributes to disease progression (8). The difference in the response of inflamed tissues to C3a, between the acute and chronic phases of inflammation, may well be due to the differing cell types involved (e.g., neutrophils versus monocyte/ macrophages; Fig.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In the acute setting, C3a prevents mobilization of neutrophils, limits their accumulation into tissues, and, therefore, reduces the inflammatory response at the tissue level. However, in certain chronic disease models, such as asthma and rheumatoid arthritis, C3a clearly demonstrates certain proinflammatory actions and contributes to disease progression (8). The difference in the response of inflamed tissues to C3a, between the acute and chronic phases of inflammation, may well be due to the differing cell types involved (e.g., neutrophils versus monocyte/ macrophages; Fig.…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, at the site of acute inflammation, carboxypeptidases preferentially degrade C5a over C3a, perhaps allowing for C3a to escape degradation and exert systemic actions (8). We recently showed that one function of this C3a release is to attenuate the neutrophilia associated with injury by confining unmobilized neutrophils to the bone marrow reservoir (32).…”
Section: C3a In Diseasementioning
confidence: 99%
“…In both mouse and human there is a single receptor for C3a (C3a-receptor), which can also serve to mediate signaling for C3a desArg. Ligand binding and signaling by the C3a-receptor has been well characterized, a process that involves pertussis toxin-sensitive G␣ i signaling (73). Receptor signaling through the anaphylatoxin receptors can result in changes in intracellular signaling calcium levels, trigger prolonged activation of protein phosphorylation such as ERK1/2 and Akt, and may also involve arrestin binding to the phosphorylated receptor.…”
Section: Discussionmentioning
confidence: 99%
“…4 Complement can be activated through the classical, alternative, and lectin pathways that all culminate in the formation of a lytic pore in cell membranes, known as the membrane attack complex, and the production of proinflammatory small protein fragments called anaphylotoxins C3a, C5a, and C4a. 5 Blockade of C3a [6][7][8] and C5a 8,9 receptors is protective against ischemia/reperfusion in animals.…”
mentioning
confidence: 99%